Document is current
Any future updates will be listed below
-
Authors
Vanderlinden, Greet https://orcid.org/0000-0002-5673-4121
Mertens, Nathalie
Michiels, Laura
Lemmens, Robin
Koole, Michel
Vandenbulcke, Mathieu
Van Laere, Koen
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (FWO/G093218N)
Universitaire Ziekenhuizen Leuven, KU Leuven (C24-17-063)
- License Information
-
More Information
Article History
Received: 19 April 2022
Accepted: 7 July 2022
First Online: 19 July 2022
Declarations
:
: This study was part of an ongoing larger longitudinal monocentric study including <sup>18</sup>F-MK-6240 in aMCI and was approved by the local Ethics Committee and was conducted according to the latest version of the Declaration of Helsinki.
: Written informed consent was signed by all participants prior to study inclusion.
: NM is PhD mandate holder of the Fund for Scientific Research, Flanders, Belgium (FWO). RL and KVL are senior investigators of FWO Flanders. KVL and MK have performed contract research through KU Leuven for Merck, Janssen Pharmaceuticals, UCB, Cerveau, Syndesi, Eikonizo, GE Healthcare, and Curasen. No other potential conflicts of interest relevant to this article exist.
